Alopecia areata

Kirsten Rønholt, Stine Simonsen, Farnam Barati Sedeh, Lone Skov

Publikation: Bidrag til tidsskriftReviewForskningpeer review


Alopecia areata (AA) is an autoimmune disease where inflammation around the lowest part of the hair follicle results in non-scarring hair loss. This review investigates the course of the disease, its unpredictability and variation from a single patch of scalp hair loss to the loss of all hair on the body. The first drug with AA indication was approved in 2022, the JAK-inhibitor baricitinib. This paves the way for future research that may lead to the development of new effective pathogenesis-specific treatments.

Bidragets oversatte titelAlopecia areata
Antal sider10
TidsskriftUgeskrift for Laeger
Udgave nummer47
StatusUdgivet - 20 nov. 2023

Bibliografisk note

Published under Open Access CC-BY-NC-BD 4.0.


  • Alopecia
  • Alopecia Areata/drug therapy
  • Autoimmune Diseases
  • Humans
  • Janus Kinase Inhibitors


Udforsk hvilke forskningsemner 'Alopecia areata' indeholder.